.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Express Scripts
US Army
Merck
AstraZeneca
Deloitte
US Department of Justice
Boehringer Ingelheim
Chubb
Mallinckrodt
Chinese Patent Office

Generated: June 28, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 090294

« Back to Dashboard
NDA 090294 describes BENZTROPINE MESYLATE, which is a drug marketed by Upsher-smith Labs, Oxford Pharms, Quantum Pharmics, Usl Pharma, Aspen Global Inc, Vintage, Navinta Llc, Fresenius Kabi Usa, Luitpold, Pliva, Epic Pharma Llc, Frontida Biopharm, Leading Pharma Llc, Lannett Holdings Inc, Hikma Farmaceutica, and Invagen Pharms, and is included in twenty-seven NDAs. It is available from thirty-three suppliers. Additional details are available on the BENZTROPINE MESYLATE profile page.

The generic ingredient in BENZTROPINE MESYLATE is benztropine mesylate. There are five drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the benztropine mesylate profile page.

Summary for NDA: 090294

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Antiparkinson Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 090294

Suppliers and Packaging for NDA: 090294

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
BENZTROPINE MESYLATE
benztropine mesylate
TABLET;ORAL 090294 ANDA Camber Pharmaceutical, Inc. 31722-218 31722-218-01 100 TABLET in 1 BOTTLE (31722-218-01)
BENZTROPINE MESYLATE
benztropine mesylate
TABLET;ORAL 090294 ANDA Camber Pharmaceutical, Inc. 31722-218 31722-218-10 1000 TABLET in 1 BOTTLE (31722-218-10)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength0.5MG
Approval Date:Mar 29, 2010TE:AARLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength1MG
Approval Date:Mar 29, 2010TE:AARLD:No

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength2MG
Approval Date:Mar 29, 2010TE:AARLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Cerilliant
Boehringer Ingelheim
Cipla
Dow
Colorcon
Farmers Insurance
Healthtrust
Johnson and Johnson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot